Dental Lasers Market Size To Hit USD 1,530.6 Million By 2026: Grand View Research Inc.

San Francisco, 30 April 2020: The Report Dental Lasers Market Size, Share & Trends Analysis Report By Product (Soft Tissue, All Tissue), By Application (Conservative Dentistry, Endodontic Treatment), By End Use (Hospitals, Dental Clinics), And Segment Forecasts, 2019 – 2026

The global dental lasers market size is expected to reach USD 1,530.6 million by 2026, according to a new report by Grand View Research Inc. It is projected to register a CAGR of 6.5% during the forecast period. Rising application of dental lasers for the treatment of dental diseases and procedures, such as cavity preparation, dentinal hypersensitivity, restorative removal, growth modulation, and caries prevention, is contributing to the growth. In addition, increasing adoption in hyperplastic tissue removal, wound healing, photostimulation of herpetic lesions, and photodynamic therapy for malignancies is anticipated to fuel the demand.

Advantages such as high efficiency, less bleeding, better control of soft tissue, and comfortable treatment are anticipated to further fuel the demand for dental lasers. Additionally, many insurance policies cover the usage of dental lasers for conservative soft tissue, therefore fueling market growth. Technological advancements are predicted to offer lucrative opportunities in the forthcoming years. Growing use of lasers in dentistry domain coupled with increasing acceptance of devices with novel technologies by dental surgeons are few emerging trends witnessed in the market.

Access Research Report of Dental Lasers Market @ https://www.grandviewresearch.com/industry-analysis/dental-lasers-market

Further key findings from the report suggest:

• Soft tissue is the fastest growing segment owing to the rising number of soft tissue disorders, such as periodontal disorders and gingivitis. Diode lasers are majorly used in soft tissues procedures, driving the segment growth
• Oral surgery segment is expected to witness lucrative growth in the next seven years owing to the rise in the number of patients demanding bone and gum tissue restructuring. Rising awareness regarding oral hygiene is expected to further impel the growth
• Hospital segment is expected to expand at a CAGR of 5.7% by 2026 owing to improving healthcare facilities in the emerging economies and well-established medical settings in the developed nations
• North America dental laser market has been estimated to be the largest owing to rise in awareness regarding oral hygiene, increasing incidence of dental diseases such as gingivitis, periodontics, and caries
• Key players of dental laser market include Biolase, Inc.; AMD LASERS; FOTONA D.D.; Ivoclar Vivadent AG; Danaher; Dentsply Sirona Inc.; Syneron Dental; ZOLAR Technology & Mfg Co. Inc.; THE YOSHIDA DENTAL MFG. CO., LTD.; and Convergent Dental

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global dental laser market on the basis of product, application, end use, and region:

Dental Lasers Product Outlook (Revenue, USD Million, 2015 – 2026)

• Soft Tissue
• All Tissue
• Dental Welding Lasers

Dental Lasers Application Outlook (Revenue, USD Million, 2015 – 2026)

• Conservative Dentistry
• Endodontic Treatment
• Oral Surgery
• Implantology
• Peri-Implantitis
• Periodontics
• Tooth Whitening.

Dental Lasers End Use Outlook (Revenue, USD Million, 2015 – 2026)

• Hospitals
• Dental Clinics

Dental Lasers Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Dental Lasers Market @ https://www.grandviewresearch.com/press-release/global-dental-laser-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Emergency Medical Services Products Market Demand With Top Key Players In The Globe By Historical And Future Forecast Data Till 2026 : Grand View Research Inc.

San Francisco, 30 April 2020: The Report Emergency Medical Services Products Market Size, Share & Trends Analysis Report By Product (Patient Monitoring Systems, Life Support & Emergency Resuscitation), By Region, And Segment Forecasts, 2019 – 2026

The global emergency medical services products market size is expected to reach USD 34.15 billion by 2026 registering a CAGR of 7.0%, according to a new report by Grand View Research, Inc. Increasing demand for emergency care and increasing healthcare expenditure across the globe are the key factors driving the market. Increasing cases of trauma, caused by road accidents, natural disasters, and sports and other injuries, is also one of the key growth-driving factors for the market.

For instance, as per the Centers for Disease Control and Prevention (CDC), traumatic brain injury is the major cause of disability and death in U.S., accounting for 30.0% of all injury-related deaths. Emergency medical services (EMS) and trauma centers work closely to initiate the pre-hospital treatment process. In U.S., the government introduced Emergency Medical Treatment and Labor Act (EMTALA) in 1986. As per the law, anyone going to the emergency department has to be treated and stabilized, irrespective of their ability to pay or their insurance status.

Such laws are improving the accessibility of emergency care. In addition, rising healthcare expenditure across the globe is likely to improve the quality of emergency medical services. Such factors are expected to boost the EMS products market over the forecast period. Moreover, associations, such as American Trauma Society (ATS), offer courses and training for preventing injuries, which drives the demand for EMS products. ATS offers a two-day course developed by seasoned injury prevention professionals across the country.

Access Research Report of Emergency Medical Services Products Market @ https://www.grandviewresearch.com/industry-analysis/emergency-medical-services-ems-products-market

Further key findings from the study suggest:

• In terms of revenue, life support & emergency resuscitation systems led the EMS products market in 2018 and will continue its dominance throughout the forecast years
• Increasing cases of trauma and demand for emergency care contributes to the growth of the life support & emergency resuscitation systems segment
• Defibrillators segment is expected to witness the fastest growth over the forecast period owing to the rise in number of Cardiovascular Diseases (CVDs).
• Asia Pacific is expected to witness the fastest CAGR from 2019 to 2026 owing to rapid development of healthcare infrastructure and rising number of start-ups in this region
• Prominent key companies in the market are Bound Tree Medical; McKesson Medical-Surgical, Inc.; Stryker Corp.; and Medline Industries, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global EMS products market on the basis of product and region:

EMS Product Outlook (Revenue, USD Million, 2015 – 2026)

• Life Support & Emergency Resuscitation
  • Defibrillators
  • Endotracheal Tubes
  • Ventilators
  • Resuscitators
  • Laryngoscopes
• Patient Monitoring Systems
• Wound Care Consumables
  • Dressings & Bandages
  • Sutures & Staples
  • Others
  • Musculoskeletal
  • Others
• Patient Handling Equipment
  • Medical Beds
  • Wheelchairs and Scooters
  • Other Equipment
• Infection Control Supplies
  • Disinfectant and Cleaning Agents
  • Personal Protection Equipment
  • Others
• Other EMS Products

EMS Products Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia-Pacific
• Latin America
• MEA

Access Press Release of Emergency Medical Services Products Market @ https://www.grandviewresearch.com/press-release/global-emergency-medical-services-ems-products-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Mexico Medical Cannabis Market Size Is Projected To Reach USD 249.6 Million By 2025: Grand View Research Inc.

San Francisco, 30 April 2020: The Report Mexico Medical Cannabis Market Size, Share & Trends Analysis Report By Application (Chronic Pain, Cancer), By Product (Oils, Buds, Tinctures), And Segment Forecasts, 2019 – 2025

The Mexico medical cannabis market size is expected to reach USD 249.6 million by 2025, exhibiting a CAGR 27.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising adoption of medicinal marijuana for the treatment of chronic conditions such as Alzheimer’s disease, cancer, arthritis, anxiety, and epilepsy is one of the key factors propelling the Mexican medical cannabis market. Furthermore, approval of CBD derivatives for medicinal use is also expected to drive demand in the coming years.

The cannabis industry is booming due to its increasing adoption for medicinal application and imminent legalization for recreational use. In Mexico, marijuana is only legalized for medicinal use and is anticipated to be legalized for recreational purposes in an effort to abolish illicit drug trade and generate tax revenue.

Competition among existing players is moderately high as very few companies have the technology, financial resources, and legal clearance to venture into large-scale manufacturing of marijuana. Medical marijuana has been legalized in Mexico since June 2017. Health licenses for cultivation, harvesting, and production of marijuana in the country are exclusively limited to medicinal and research purposes. Laws pertaining to marijuana are not that well-regulated in the nation and go through a secondary regulation by Federal Commission for the Protection against Health Risks.

Access Research Report of Mexico Medical Cannabis Market @ https://www.grandviewresearch.com/industry-analysis/mexico-medical-cannabis-market

Further key findings from the report suggest:

• In 2018, buds held the largest revenue share accounting for 47.4% owing to easy availability and low price as compared to cannabis extracts
• Cannabis oil is anticipated to emerge as the fastest growing segment, expanding at a CAGR of 33.1% between 2019 and 2025
• Chronic pain held the largest revenue share based on application, owing to rapid adoption of marijuana for the treatment of chronic pain as an alternative to opioids and synthetic drugs
• Key players in this space include Aurora Cannabis; GW Pharmaceuticals plc.; Canopy Growth Corporation; HempMeds; CV Sciences Inc.; Endoca; Isodiol International Inc.; CBD Life; Pharmacielo; CBD American Shaman; and Elixinol.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Mexico medical cannabis market on the basis of product and application:

Mexico Medical Cannabis Product Outlook (Revenue, USD Million, 2014 – 2025)

• Buds
• Oils
• Tinctures

Mexico Medical Cannabis Application Outlook (Revenue, USD Million, 2014 – 2025)

• Chronic Pain
• Mental Disorders
• Cancer
• Others

Access Press Release of Mexico Medical Cannabis Market @ https://www.grandviewresearch.com/press-release/mexico-medical-cannabis-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Nephrostomy Devices Market Size Worth $ 1.71 Billion By 2026: Grand View Research Inc.

San Francisco, 30 April 2020: The Report Nephrostomy Devices Market Size, Share & Trends Analysis Report By Product (Guidewires, Nephrostomy Catheters), By End Use (ASCs, Hospitals), By Region, And Segment Forecasts, 2019 – 2026

The global nephrostomy devices market size is anticipated to reach USD 1.71 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.

North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.

Access Research Report of Nephrostomy Devices Market @ https://www.grandviewresearch.com/industry-analysis/nephrostomy-devices-market

Further key findings from the study suggest:

• Guidewires segment led the global nephrostomy devices market in 2018 and is anticipated to expand further at the highest CAGR from 2019 to 2026
• The segment growth is attributed to rising cases of kidney and urine related disorders, and preference for guidewires as they are less invasive
• The hospital segment dominated the market in 2018. Percutaneous nephrostomy are majorly performed in the hospitals as compared to the emergency clinics, which drives the segment growth
• ASCs segment is anticipated to register the highest CAGR as nephrostomy devices are widely used by ASCs due to their benefits, such as significant cost saving and personalized services
• North America leads the market due to high prevalence of target diseases, availability of skilled surgeons, presence of well-established healthcare sector, and quick adoption of advanced medical tools
• Key companies in the market focus on strategies, such as innovations in the existing products, introduction of new products, and mergers and acquisitions to strengthen their presence in the industry

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nephrostomy devices market on the basis of product, end use, and region:

Nephrostomy Devices Product Outlook (Revenue, USD Million, 2015 – 2026)

• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Nephrostomy Devices End Use Outlook (Revenue, USD Million, 2015 – 2026)

• Hospitals
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)

Nephrostomy Devices Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Access Press Release of Nephrostomy Devices Market @ https://www.grandviewresearch.com/press-release/global-nephrostomy-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Plant Biotechnology Equipment Market Projected To Exhibit Robust CAGR of 12.8% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 30 April 2020: The Report Plant Biotechnology Equipment Market Size, Share & Trends Analysis Report By Plant Phenotyping, By Plant Genotyping, By Cell Culture, By Smart Farm Equipment, By Region, And Segment Forecasts, 2018 – 2025

The global plant biotechnology equipment market size is estimated to reach USD 18.35 billion by 2025, according to the new report by Grand View Research, Inc. it is likely to expand at a CAGR of 12.8% over the forecast period. High demand for transgenic crops and biofuel is driving the market growth. Demand for transgenic crops has been rising owing to various benefits, such as improvement in yield, productivity, and quality of output and development of insect-resistant cultivars in crops.

In transgenic plants, one or more species are introduced in the genome using genetic engineering processes. Inserting a combination of genes in a plant makes it more productive. Transgenic plants are also produced to cater to particular needs of pharmaceutical sector. Advent of various genetic engineering processes is expected to drive the market growth over the forecast period.

Advanced techniques, such as next-generation DNA sequencing, can be availed by breeders to boost the rate of genetic improvement by molecular breeding. Plant cell culture methods can also be used for enhancing food grain quality and for increasing food production. These methods are also useful for postharvest applications of food materials. Plant biotech equipment, such as plant phenotyping equipment, cell culture equipment, and smart farm equipment, can play an instrumental role in these methods.

Advances in biotechnology and rising use of biotech equipment for biofuel production are anticipated to further drive the growth of the plant biotech equipment market over the forecast period. Biofuel is gaining popularity due to rising crude oil prices and uncertainty in fuel supply stemming from depleting natural resources. Biofuel is considered as one of the alternatives to fossil fuels owing to its various benefits.

Biofuel can be produced domestically, can be cheaper than fossil fuels, and is also environment-friendly. Technological challenges associated with biofuel production can be addressed using biotech solutions and equipment, which in turn, is expected to boost the demand for plant biotech equipment over the forecast period.

 

Access Research Report of Plant Biotechnology Equipment Market @ https://www.grandviewresearch.com/industry-analysis/plant-biotechnology-equipment-market

Further key findings from the report suggest:

• Rapidly rising global population has boosted demand for agricultural produce
• Advances in technology coupled with increasing government funding have enabled the plant biotechnology industry to grow at a significant growth rate in recent years
• Agriculture sector has witnessed tremendous developments in terms of advanced technologies in recent times. Usage of electronic sensors, smart devices, and other biotechnological methods have transformed conventional farming into innovative and sustainable farming
• Benefits, such as high-quality crops and increased yield, facilitated by biotech equipment are expected to drive the growth of plant biotech equipment market over the forecast period
• Advancements in imaging techniques are facilitating a better assessment of plant characteristics, thereby helping in developing better plants breeds.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global plant biotechnology equipment market based on plant phenotyping equipment, plant genotyping equipment, cell culture equipment, smart farm equipment, and region:

Plant Biotechnology Equipment: Plant Phenotyping Equipment Outlook (Revenue, USD Million, 2013 – 2025)

• Hardware
  • Sensors Modules
    • Ultrasonic Distance Sensors
    • NDVI Sensors
    • RGB Web Cameras
    • Portable Spectrometers
    • Temperature Sensors
    • Humidity Sensors
  • Imaging devices
    • Infrared Imaging
    • Fluorescence Imaging
    • Structural Tomography
    • Position Emission Tomography (PET)
    • Hyperspectral Imaging
    • Others (Magnetic Resonance Imaging, Forster Resonance, Energy Transfer, NIR imaging)
  • Automated System
    • Bench-based
    • Conveyor-based
  • Drones
  • LED Lighting
  • Portable Devices
• Software
• End Use
  • Greenhouse
  • Field
  • Laboratory
• Application
  • Plant Research
  • Breeding
  • Product Development
  • Quality Assessment

Plant Biotechnology Equipment: Plant Genotyping Equipment Outlook (Revenue, USD Thousand, 2013 – 2025)

• End Use
  • Greenhouse
  • Field
  • Laboratory
• Application
  • Plant Research
  • Breeding
  • Product Development
  • Quality Assessment

Plant Biotechnology Equipment: Cell Culture Equipment Outlook (Revenue, USD Million, 2013 – 2025)

• Equipment
  • Incubators
  • Centrifuges
  • Seed Germinators
  • Microscopes
  • Sterilizer
  • Cell Counter
  • Others (autoclave, shaker, refrigerator, pH meter, cell culture vessels, syringes & needles)
• End Use
  • Greenhouse
  • Field
  • Laboratory
• Application
  • Plant Research
  • Breeding
  • Product Development
  • Quality Assessment

Plant Biotechnology Equipment: Smart Farm Equipment Outlook (Revenue, USD Million, 2013 – 2025)

• Hardware
  • Automation & Control System
    • Drones
    • Application Control Devices
    • Guidance System
      • GPS
      • GIS
    • Remote Sensing
      • Hand Held
      • Satellite Sensing
    • Driverless Tractors
    • Mobile Devices
    • Variable Rate Technology
      • Map-based
      • Sensor-based
    • Wireless Modules
    • Bluetooth Technology
      • Wi-Fi Technology
      • Zigbee
      • RF Technology
    • Sensing Devices
      • Soil Sensor
      • Nutrient Sensor
      • Moisture Sensor
      • Temperature Sensor
      • Water Sensor
      • Climate Sensor
      • Others
    • Antennas/Access Points
  • Software
    • Web-based
    • Cloud-based
  • End Use
    • Greenhouse
    • Field
    • Laboratory
  • Application
    • Plant Research
    • Breeding
    • Product Development
    • Quality Assessment

Plant Biotechnology Equipment: Regional Outlook (Revenue, USD Million, 2013 – 2025)

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Access Press Release of Plant Biotechnology Equipment Market @ https://www.grandviewresearch.com/press-release/global-plant-biotechnology-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Plant Cell Culture Equipment Market Projected To Expand At A CAGR 13.1% For The Forecast Period From 2019 To 2025: Grand View Research Inc.

San Francisco, 30 April 2020: The Report Plant Cell Culture Equipment Market Size, Share & Trends Analysis Report By End Use (Greenhouse, Field), By Equipment (Seed Germinators, Incubators), By Application, By Region, And Segment Forecasts, 2018 – 2025

The global plant cell culture equipment market size is estimated to reach USD 1.05 billion by 2025, according to a new report by Grand View Research, Inc. The global market is estimated to register a CAGR of 13.1% during the forecast years. The demand for transgenic crops has been rising owing to various benefits offered by these crops, such as improvement in the yield, productivity, and quality and development of insect-resistant cultivars in crops. Transgenic plants are the ones whose genomes are modified using genetic engineering processes in order to introduce more species or new traits to the plant. Inserting a combination of genes in a plant makes the plant more productive.

Transgenic plants are also produced to cater to specific needs of the pharmaceutical sector. Emergence of various genetic engineering processes is expected to drive the market over the forecast period. Plant cell culture systems are a potential renewable source of valuable medicinal compounds, colorants, fragrances, and flavors; which are difficult to be produced by chemical synthesis or microbial cells. Plant cell culture technology enables the development of agricultural crops that offer both higher yield and more resistance to pathogens and adverse environmental conditions. Moreover, this technology could be used in providing a reliable and continuous source of plant pharmaceuticals.

Plant cell culture can be used as an alternative to the cultivation or collection of plants. The number of natural products isolated using plant cell cultures is huge and is increasing gradually. On a large scale, unlike the culture of microorganisms, the cells are cultured in a fermenter. The fermentation process offers certain advantages over the collection of plant material or field cultivation for the isolation of high-value chemicals. These advantages include continuous supply of plants as raw material and production of entirely new compounds and plant cells under controlled conditions.

Access Research Report of Plant Cell Culture Equipment Market @ https://www.grandviewresearch.com/industry-analysis/plant-cell-culture-equipment-market

Further key findings from the report suggest:

• Rapidly increasing population has boosted the demand for agricultural produce, thereby augmenting the growth of this market
• Increasing research and development in the field of cell and tissue engineering has also contributed toward the market development
• North America regional market is expected to witness a significant growth owing to increasingresearch activities in plant cell culture
• Key market participants include Thermo Fisher Scientific, Inc. (U.S.); Tecan Group Ltd. (Switzerland); LGC Limited (London); LabRepCo, Inc. (U.S.); Geneq, Inc. (Canada); and Conviron (Canada).

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global plant cell culture equipment market on the basis of equipment, end use, application, and region:

Plant Cell Culture Equipment Outlook (Revenue, USD Million, 2013 – 2025)

• Incubators
• Centrifuges
• Seed Germinators
• Microscopes
• Sterilizers
• Cell Counters
• Others

Plant Cell Culture Equipment End-use Outlook (Revenue, USD Million, 2013 – 2025)

• Greenhouse
• Field
• Laboratory

Plant Cell Culture Equipment Application Outlook (Revenue, USD Million, 2013 – 2025)

• Plant Research
• Breeding
• Product Development
• Quality Assessment

Plant Cell Culture Equipment Regional Outlook (Revenue, USD Million, 2013 – 2025)

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Access Press Release of Plant Cell Culture Equipment Market @ https://www.grandviewresearch.com/press-release/global-plant-cell-culture-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Plant Phenotyping Equipment Market Likely To Touch At USD 276.86 Million By 2025: Grand View Research Inc.

San Francisco, 30 April 2020: The Report Plant Phenotyping Equipment Market Size, Share & Trends Analysis Report By Equipment, By End Use (Greenhouse, Field, Laboratory), By Application, By Region, And Segment Forecasts, 2018 – 2025

The global plant phenotyping equipment market size is estimated to reach USD 276.86 million by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.51% over the forecast period. Global population is projected to surpass 9 billion by 2050, thus posing the challenge of adequate crop production to meet rising food needs. This, in turn, is expected to open up potential opportunities for crop improvement and plant science. However, adequate crop production would be challenging, particularly since crop production has been rising by approximately 1.3% per year on an average. This is not sufficient to meet the pace of population growth. Plant phenotyping is emerging as an effective means to overcome this challenge. Thus, the plant phenotyping equipment market is expected to witness significant growth over the forecast period.

Plants have different optical properties; healthy plants transmit, emit, reflect, absorb, and fluoresce with electromagnetic radiation in a different manner as compared to infected plants. Imaging techniques assist in detecting these properties, particularly those invisible to naked eye. Imaging methodologies, such as imaging spectroscopy, infrared imaging, fluorescence imaging, and visible light imaging among others, are increasingly being used to aggregate multi-level phenotype data. This data ranges from macroscopic to molecular scale for a duration of a few seconds to a few weeks.

Spectroscopy imaging helps measure interaction of solar radiation with plants and is one of the promising methodologies used for plant phenotyping. This methodology is suitable for field phenotyping when used with aerial platforms. However, cost of spectral cameras is comparatively higher. Infrared imaging technologies aid in screening objects of internal molecular movements which release infrared radiation and offer precise measurement and spatial resolution under altering environmental conditions.

Fluorescence imaging is used in many areas of plant physiology. It provides diagnostic tools to resolve heterogeneity issue of leaf photosynthetic performance. Its applications are limited to a single leaf or seedling levels of a model crop. Visible light imaging is easy to use and cost-effective. This imaging system offers 2D images using a wavelength perception similar to the human eye. The images can be used to monitor changes in a plant’s biomass and to study numerous phenotypic characteristics.

Access Research Report of Plant Phenotyping Equipment Market @ https://www.grandviewresearch.com/industry-analysis/plant-phenotyping-equipment-market

Further key findings from the report suggest:

• Rapidly increasing population across the world has boosted demand for agricultural goods
• Advancements in imaging techniques are facilitating a better assessment of plant characteristics, thereby helping in development of better plant breeds
• North America plant phenotyping equipment market is expected to witness significant growth owing to increasing research activities
• Key market participants include Keygene; Heinz Walz GmbH; LemnaTec GmbH; Photon Systems Instruments; spol. s.r.o.; and Qubit Systems Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global plant phenotyping equipment market on the basis of equipment, end use, application, and region:

Plant Phenotyping Equipment Outlook (Revenue, USD Million, 2013 – 2025)

• Hardware
  • Sensor modules
    • Ultrasonic Distance Sensors
    • NDVI Sensors
    • RGB Web Cameras
    • Portable Spectrometers
    • Temperature Sensors
    • Humidity Sensors
  • Imaging devices
    • Infrared Imaging
    • Fluorescence Imaging
    • Structural Tomography
    • Position Emission Tomography (PET)
    • Hyperspectral imaging
    • Others (Magnetic Resonance Imaging, Forster Resonance Energy Transfer, NIR Imaging)
  • Automated System
    • Bench-based
    • Conveyor based
  • Drones
  • LED Lightings
  • Portable Devices
• Software

Plant Phenotyping Equipment End Use Outlook (Revenue, USD Million, 2013 – 2025)

• Greenhouse
• Field
• Laboratory

Plant Phenotyping Equipment Application Outlook (Revenue, USD Million, 2013 – 2025)

• Plant Research
• Breeding
• Product Development
• Quality Assessment

Plant Phenotyping Equipment Regional Outlook (Revenue, USD Million, 2013 – 2025)

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Access Press Release of Plant Phenotyping Equipment Market @ https://www.grandviewresearch.com/press-release/global-plant-phenotyping-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Plant Genotyping Equipment Market is Predicted to Observe a Tremendous Growth, With a CAGR of 9.6% From 2018 To 2025 : Grand View Research Inc.

San Francisco, 30 April 2020: The Report Plant Genotyping Equipment Market Size, Share & Trends Analysis Report By End Use, By Equipment (SNP Genotyping Equipment, Liquid Handler), By Application (Breeding, Product Equipment), And Segment Forecasts, 2018 – 2025

The global plant genotyping equipment market size is estimated to reach USD 895.45 million by 2025 at a 9.6% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Next-Generation Sequencing (NGS) techniques have proved to be exceptional tools for identification, assessment, and validation of genetic markers. As a result, they have facilitated the development of array-based genotyping platforms and genome-wide SNP markers.

High-throughput Single Nucleotide Polymorphism (SNP) genotyping delivers various benefits over previous marker systems, which include different genotyping systems in order to meet different needs, rapid processing of large populations, and an abundance of markers. Prominent benefits of SNP markers include ease of data management along with cost-effectiveness, speed, and flexibility. Bi-allelic SNP markers create large databases of marker information and the data can be easily merged across groups.

Expansion of SNP genotyping techniques has led to large-scale investment by life science companies to develop genotyping and sophisticated sequencing platforms that leverage recent developments in automation, computer science, and nanotechnology. The genotyping platforms have been highly optimized for cost-effectiveness, robustness, efficiency, and speed. Additionally, many of the approaches are automated, which has enabled to free-up staff from repetitive hands-on work to do more effective functions in applying new tools for breeding applications, integrating phenotype data, and managing and analyzing genotype data.

Access Research Report of Plant Genotyping Equipment Market @ https://www.grandviewresearch.com/industry-analysis/plant-genotyping-equipment-market

Further key findings from the report suggest:

• From personalized genetic testing to plant biotechnology, the use of SNP genotyping is growing rapidly
• SNP is an upcoming area of interest for researchers engaged in genomics and life science studies
• The North America plant genotyping equipment market is expected to witness significant growth owing to increasing research activities in plant genotyping
• Key industry participants include Illumina, Inc. (U.S.); LGC Limited (UK); and Evogene Ltd. (Israel).

 

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global plant genotyping equipment market on the basis of equipment, end use, application, and region:

Plant Genotyping Equipment Outlook (Revenue, USD Thousand, 2013 – 2025)

• SNP Genotyping Equipment
• Real-time PCR Instrument
• DNA Analyzer
• Liquid Handler
• Others

Plant Genotyping Equipment End Use Outlook (Revenue, USD Thousand, 2013 – 2025)

• Greenhouse
• Field
• Laboratory

Plant Genotyping Equipment Application Outlook (Revenue, USD Thousand, 2013 – 2025)

• Plant Research
• Breeding
• Product Development
• Quality Assessment

Plant Genotyping Equipment Regional Outlook (Revenue, USD Thousand, 2013 – 2025)

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Access Press Release of Plant Genotyping Equipment Market @ https://www.grandviewresearch.com/press-release/global-plant-genotyping-equipment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

 

U.S. Pharmacy Benefit Management Market Likely To Touch At USD 744.6 Billion By 2026: Grand View Research Inc.

San Francisco, 29 April 2020: The Report U.S. Pharmacy Benefit Management (PBM) Market Analysis Report By Business Model (Standalone, Health Insurance Providers, Retail Pharmacy), By End Use (Commercial, Federal), And Segment Forecasts, 2019 – 2026

The U.S. pharmacy benefits management market size is projected to reach USD 744.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.2% during the forecast period. Increasing vertical integration of key market players, rising prevalence of chronic disease, and shrinking FDA generic-approval backlog are some of the primary growth stimulants for the market.

Vertical integration of pharmacy benefits management (PBM) organizations with health insurance companies are poised to result in increased control of PBMs over distribution systems. This will lead to rise in rebates, ultimately increasing the cost of drug list prices. Moreover, it will result in a monopoly of certain market player, concentrating sales and revenue generation.

The business of insuring and administering employee benefit programs in the country, especially, health care programs, is heavily regulated by federal and state laws and administrative agencies, such as the Department of Health and Human Services (HHS), State Departments of Insurance, Centers for Medicare & Medicaid Services (CMS), Internal Revenue Services, and Departments of Labor.

All PBM businesses in the U.S. must include home delivery and specialty pharmacies licensed as pharmacies in the states of establishment. Several states in the country regulate the scope of prescription (Rx) drug coverage and delivery channels to receive drugs for managed care organizations (MCOs), insurers, and Medicaid care plans. Certain home delivery and specialty pharmacies must be registered with the U.S. Drug Enforcement Administration (DEA) and individual state controlled substance authorities.

Access Research Report of U.S. Pharmacy Benefit Management Market @ https://www.grandviewresearch.com/industry-analysis/us-pharmacy-benefit-management-pbm-market

Further key findings from the study suggest:

• Based on business model, the market has been segmented into standalone PBM, health insurance providers, and retail pharmacy. Of these, PBMs associated with health insurers are likely to witness the fastest growth over the forecast period
• Rise in mergers and partnerships between market players is expected to result in an increased demand for PBM systems
• OptumRx and Express Scripts (merged with Cigna in December 2018) are among the key players merged or acquired by large health insurance providers
• Based on end use, the market has been divided into commercial and federal. Commercial PBM systems dominated the market and are estimated to maintain their dominance through 2026 owing to a large number of covered patients
• CVS Health; Aetna; Express Scripts; Cigna; OptumRx, Inc.; Walgreens Booth Alliance; MedImpact Healthcare Systems, Inc.; Anthem; and Rite Aid are some of the key players in the market.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the U.S. pharmacy benefits management (PBM) market based on business model and end use:

Business Model Outlook (Revenue, USD Billion, 2015 – 2026)

• Standalone PBMs
• Health Insurance Providers
• Retail Pharmacy

End Use Outlook (Revenue, USD Billion, 2015 – 2026)

• Commercial
• Federal

Access Press Release of U.S. Pharmacy Benefit Management Market @ https://www.grandviewresearch.com/press-release/us-pharmacy-benefit-management-pbm-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Phenylketonuria Treatment Market Size Is Poised To Reach USD 1.02 Billion By 2026: Grand View Research Inc.

San Francisco, 29 April 2020: The Report Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq, CNSA-001, SYNB1618), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2019 – 2026

The global phenylketonuria treatment market size is expected to reach USD 1.02 billion by 2026 registering a CAGR of 11.0%, according to a new report by Grand View Research, Inc. Rising prevalence of PKU across the world and favorable government regulations are the factors expected to spur the market growth over the forecast period.

For instance, according to the FDA, in 2018, phenylketonuria affected about 1 in 10,000 to 15,000 people in U.S. Furthermore, according to the Orphanet, it was estimated that 1 in 10,000 newborns in Europe is suffering from PKU. The target disease is highly prevalent in European countries, such as Italy, Ireland, and Turkey. It was estimated that around 1 in 4000 individuals in Turkey were diagnosed with PKU.

Various awareness programs conducted by private and public organizations are also projected to fuel market growth. Some of the organizations conducting such programs are SickKids, Children’s Hospital of Wisconsin, CHOC Children’s, and Boston Children’s Hospital. These programs aim to promote optimal emotional, developmental, and physical health PKU patients.

Furthermore, continuous R&D for the disease treatment is estimated to enhance the market growth. For instance, Synlogic, Inc.’s SYNB1618 drug is undergoing Phase 1/2a clinical trials and also received fast-track designation from FDA. In addition, other companies, such as Rubius Therapeutics, Inc., Retrophin, Inc., and Homology Medicines, Inc. are also conducting research to develop novel therapies, such as oral, enzyme therapy, gene therapy.

Availability of reimbursement policies for high-cost treatments of PKU is also projected to boost the market growth. Kuvan is currently approved for use and reimbursed in many European countries, such as Germany, Belgium, France, Italy, and Austria. Furthermore, increasing number of funding programs for R&D by various organizations is anticipated to drive the market. For instance, the National PKU Alliance provides funding to research projects that helps in promoting advances in the management and treatment of PKU.

Access Research Report of Phenylketonuria Treatment Market @ https://www.grandviewresearch.com/industry-analysis/phenylketonuria-pku-treatment-market

Further key findings from the study suggest:

• Kuvan held the largest market share in 2018 as it is the first and only approved drug for PKU treatment since 2007
• North America dominated the phenylketonuria treatment market in 2018 owing to the presence of well-established healthcare infrastructure, high healthcare expenditure, and favorable government regulations
• Europe region is expected to exhibit the fastest CAGR over the forecast period owing to rising R&D activities for the development of new PKU drugs
• Major companies in the market are BioMarin Pharmaceuticals, Inc.; Retrophin, Inc.; Synlogic, Inc.; Censa Phamraceuticals; Homology Medicinces, Inc.; and Rubius Therapeutics, Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global phenylketonuria treatment market on the basis of drug and region:

Phenylketonuria Treatment Drug (Revenue, USD Million, 2015 – 2026)

• Kuvan
• Palynziq
• CNSA-001
• SYNB1618

Phenylketonuria Treatment Regional Outlook (Revenue, USD Million, 2015 – 2026)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Access Press Release of Phenylketonuria Treatment Market @ https://www.grandviewresearch.com/press-release/global-phenylketonuria-pku-treatment-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com